Dow Obtains Patents for Production of Glycoproteins In Transgenic Plant Systems
A Critical Step for More Effective Biopharmaceuticals
According to Kurt Hoeprich, Director of Market Development for Dow Plant- Based Biopharmaceuticals, Dow views the glycosylation technology involved in these patents as a significant event in the field of biopharmaceutical production using a plant-based approach.
By enabling the production of mammalian-like glycan structures, the new technology can potentially equip the plant-based approach to help overcome the high capital costs and production capacity limitations of current manufacturing methods. Hoeprich adds that the technology could possibly overcome the problem of incomplete glycosylation that can occur with other expression systems.
"Meeting these challenges can result in lower production costs, increased half-life of the protein in the body, and increased clinical effectiveness," Hoeprich said. "Clearly, this is a critical step toward more effective and economical biopharmaceuticals."
Dow earlier formed research and licensing agreements with Epicyte Pharmaceutical Inc., a biopharmaceutical company focused on the discovery and development of therapeutics to treat inflammatory and infectious diseases, to develop and produce monoclonal antibodies in plant-based systems. Dow and Epicyte subsequently entered into an agreement with Centocor, Inc. to evaluate production of a therapeutic human monoclonal antibody in plants. According to Hoeprich, this latest technology acquisition is in keeping with Dow's stated strategy to assume a leadership position as a development and manufacturing resource for the pharmaceutical industry.
Topics
Organizations
Other news from the department research and development
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
Most read news
More news from our other portals
See the theme worlds for related content
Topic world Antibodies
Antibodies are specialized molecules of our immune system that can specifically recognize and neutralize pathogens or foreign substances. Antibody research in biotech and pharma has recognized this natural defense potential and is working intensively to make it therapeutically useful. From monoclonal antibodies used against cancer or autoimmune diseases to antibody-drug conjugates that specifically transport drugs to disease cells - the possibilities are enormous
Topic world Antibodies
Antibodies are specialized molecules of our immune system that can specifically recognize and neutralize pathogens or foreign substances. Antibody research in biotech and pharma has recognized this natural defense potential and is working intensively to make it therapeutically useful. From monoclonal antibodies used against cancer or autoimmune diseases to antibody-drug conjugates that specifically transport drugs to disease cells - the possibilities are enormous
Topic world biopharmaceutical manufacturing
Biopharmaceutical production plays a crucial role in the development and manufacture of biologics, which are essential for the treatment of various serious diseases. Various key technologies and processes of the modern biopharmaceutical industry are used, such as cell cultures, fermentation processes and the purification of biological substances, which are necessary for the production of vaccines, monoclonal antibodies and other biological drugs.
Topic world biopharmaceutical manufacturing
Biopharmaceutical production plays a crucial role in the development and manufacture of biologics, which are essential for the treatment of various serious diseases. Various key technologies and processes of the modern biopharmaceutical industry are used, such as cell cultures, fermentation processes and the purification of biological substances, which are necessary for the production of vaccines, monoclonal antibodies and other biological drugs.